Ashish Bose is a veteran demographer whose expertise in analysing population data persuaded the former Prime Minister, the late Rajiv Gandhi to make him an advisor on issues ranging from urbanisation to poverty alleviation. He is best known for coining the term Bimaru (shorthand for Bihar, Madhya Pradesh, Rajasthan and Uttar Pradesh) for states with the worst socio-economic indicators. An author of 24 books, he is now working on a...
More »SEARCH RESULT
Once Again without Credibility
-Economic and Political Weekly Budget 2012, built yet again at the altar of fiscal fundamentalism, will not convince anybody. In this era of immediate assessment it took just a few minutes for the Union Budget for 2012-13 to be given one or the other negative appellation – “lacklustre”, “anti-growth”, “back to the 1980s”, “without reform” and the like. Such evaluations forget that union budgets have long since ceased to be statements of...
More »Poverty line: Myths, perceptions and reality by Sriram Balasubramanian
The Planning Commission is back in the news. The latest round of poverty levels that have been disclosed have created another debate in the country. Once more, people are stunned at the meager rate of Rs 28 that has been defined as the poverty line. Even though I addressed some apprehensions in an earlier post, this time around the issue seems to be more about myths, perceptions and lack of...
More »In whose welfare?-Gaurav Choudhury
One man’s fiscal problem is another man’s lifeline. Trigger happy bureaucrats and economists may love shooting down subsidies because it bloats the fiscal deficit and burdens the government but the simple fact is that in a one billion strong nation, in which nearly one in every three live below the poverty line, one needs an effective and efficient method through which privileged tax payers can support the poor. Last week, finance...
More »India patent bypass delivers life-saving blow against cancer by Raja Murthy
India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...
More »